Benefiting from the SLAS network
Tuesday, 26 November 2024 11:50
The ÖGMBT Young Life Sciences scientist Austria (YLSA) and SLAS have recently startet a collaboration. Both benefit from their respective networks. Especially young scientists though can enhance their studies and careers being informed in depth about SLAS. Lets start with what SLAS is: The Society for Laboratory Automation and Screening (SLAS) is an international professional society of academic, industry and government researchers as well as developers and providers of laboratory automation technology and tools. SLAS leads the pursuit of research excellence by offering tangible resources such as its international conferences and symposia, scientific publishing, and opportunities for continuing education, grants and scholarships, professional collaboration, networking and career advancement. Here are "good-to-knows" about SLAS & opportunities it offers: Complimentary SLAS membership. This membership provides the YLSA network access to the 25,000+ global community of academic, industry and government researchers that are both developers and providers of laboratory automation technology and tools.…
Published in
Allgemeine News
The Gates Foundation and LifeArc*:
Tuesday, 26 November 2024 12:41
Dear Colleagues, The Gates Foundation and LifeArc* have launched a joint Grand Challenges request for proposals, "Innovations for Exceptionally Low-Cost Monoclonal Antibody (mAb) Manufacturing". Monoclonal antibodies are one of the most powerful tools in modern medicine. They are highly specific, safe, and effective medicines for a range of conditions, including treating non-communicable diseases and preventing and treating infectious diseases. These biologic therapies already save lives and improve the quality of life for many millions of patients, but high production costs continue to limit access to mAbs, especially for patients in low- and middle-income settings. While there are indication-specific dosage requirements for mAbs, it is broadly understood that to close the equity gap in mAb global access, we need to reach a target cost of $10 per gram of purified, released mAb, a goal long championed by our late colleague, Dr. Steve Hadley, former Senior Program Officer at the Gates Foundation.…
Published in
Allgemeine News
FEBS Newsletter - November 2024
Thursday, 07 November 2024 12:12
No images? Click here Just out – the November 2024 issue of FEBS News 2024 has been a special 60th anniversary year for FEBS, with several extra activities to mark the milestone and further the organization's goals. In this issue of FEBS News, enjoy a round-up of anniversary projects, discover the latest news from the journals of FEBS, browse photos from the vibrant FEBS Congress in Milano this summer – and find out plans for 2025! Browse the issue as a flipbook Download the issue as a pdf Recently announced – the FEBS Excellence Awardees 2024 It's time to congratulate the next set of early-career group leaders from the FEBS area who have been selected to receive a prestigious FEBS Excellence Award, following the call earlier this year. A FEBS Excellence Award provides funding of €100,000 for research equipment and consumables over a 3-year period. We wish the awardees much success in…
Published in
Allgemeine News
